<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5707687</article-id><article-id pub-id-type="doi">10.3390/nu9111215</article-id><article-id pub-id-type="publisher-id">nutrients-09-01215</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Pilot Study: Comparison of Sourdough Wheat Bread and Yeast-Fermented Wheat Bread in Individuals with Wheat Sensitivity and Irritable Bowel Syndrome </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Laatikainen</surname><given-names>Reijo</given-names></name><xref ref-type="aff" rid="af1-nutrients-09-01215">1</xref><xref ref-type="aff" rid="af2-nutrients-09-01215">2</xref><xref rid="c1-nutrients-09-01215" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Koskenpato</surname><given-names>Jari</given-names></name><xref ref-type="aff" rid="af2-nutrients-09-01215">2</xref></contrib><contrib contrib-type="author"><name><surname>Hongisto</surname><given-names>Sanna-Maria</given-names></name><xref ref-type="aff" rid="af3-nutrients-09-01215">3</xref></contrib><contrib contrib-type="author"><name><surname>Loponen</surname><given-names>Jussi</given-names></name><xref ref-type="aff" rid="af3-nutrients-09-01215">3</xref></contrib><contrib contrib-type="author"><name><surname>Poussa</surname><given-names>Tuija</given-names></name><xref ref-type="aff" rid="af4-nutrients-09-01215">4</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="af5-nutrients-09-01215">5</xref></contrib><contrib contrib-type="author"><name><surname>Sontag-Strohm</surname><given-names>Tuula</given-names></name><xref ref-type="aff" rid="af5-nutrients-09-01215">5</xref></contrib><contrib contrib-type="author"><name><surname>Salmenkari</surname><given-names>Hanne</given-names></name><xref ref-type="aff" rid="af1-nutrients-09-01215">1</xref></contrib><contrib contrib-type="author"><name><surname>Korpela</surname><given-names>Riitta</given-names></name><xref ref-type="aff" rid="af1-nutrients-09-01215">1</xref></contrib></contrib-group><aff id="af1-nutrients-09-01215"><label>1</label>Faculty of Medicine, Pharmacology, Medical Nutrition Physiology, University of Helsinki, 00014 Helsinki, Finland; <email>hanne.salmenkari@helsinki.fi</email> (H.S.); <email>riitta.korpela@helsinki.fi</email> (R.K.)</aff><aff id="af2-nutrients-09-01215"><label>2</label>Aava Medical Centre, 00100 Helsinki, Finland; <email>jari.koskenpato@aava.fi</email></aff><aff id="af3-nutrients-09-01215"><label>3</label>Fazer Group, 01230 Vantaa, Finland; <email>sanna-maria.hongisto@fazer.com</email> (S.-M.H.); <email>jussi.loponen@fazer.com</email> (J.L.)</aff><aff id="af4-nutrients-09-01215"><label>4</label>STAT Consulting Ltd., 37130 Nokia, Finland; <email>tpoussa@netti.fi</email></aff><aff id="af5-nutrients-09-01215"><label>5</label>Department of Food and Environmental Sciences, University of Helsinki, 00014 Helsinki, Finland; <email>xin.huang@helsinki.fi</email> (X.H.); <email>tuula.sontag-strohm@helsinki.fi</email> (T.S.-S.)</aff><author-notes><corresp id="c1-nutrients-09-01215"><label>*</label>Correspondence: <email>reijo.laatikainen@booston.fi</email>; Tel.: +358-40-7171-753</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2017</year></pub-date><volume>9</volume><issue>11</issue><elocation-id>1215</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>01</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Many patients suspect wheat as being a major trigger of their irritable bowel syndrome (IBS) symptoms. </plain></SENT>
<SENT sid="2" pm="."><plain>Our aim was to evaluate whether sourdough wheat bread baked without baking improvers and using a long dough fermentation time (&gt;12 h), would result in lower quantities of alpha-amylase/trypsin inhibitors (ATIs) and Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs), and would be better tolerated than yeast-fermented wheat bread for subjects with IBS who have a poor subjective tolerance to wheat. </plain></SENT>
<SENT sid="3" pm="."><plain>The study was conducted as a randomised double-blind controlled 7-day study (n = 26). </plain></SENT>
<SENT sid="4" pm="."><plain>Tetrameric ATI structures were unravelled in both breads vs. baking flour, but the overall reduction in ATIs to their monomeric form was higher in the sourdough bread group. </plain></SENT>
<SENT sid="5" pm="."><plain>Sourdough bread was also lower in FODMAPs. </plain></SENT>
<SENT sid="6" pm="."><plain>However, no significant differences in gastrointestinal symptoms and markers of low-grade inflammation were found between the study breads. </plain></SENT>
<SENT sid="7" pm="."><plain>There were significantly more feelings of tiredness, joint symptoms, and decreased alertness when the participants ate the sourdough bread (p ≤ 0.03), but these results should be interpreted with caution. </plain></SENT>
<SENT sid="8" pm="."><plain>Our novel finding was that sourdough baking reduces the quantities of both ATIs and FODMAPs found in wheat. </plain></SENT>
<SENT sid="9" pm="."><plain>Nonetheless, the sourdough bread was not tolerated better than the yeast-fermented bread. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>irritable bowel syndrome</kwd><kwd>wheat sensitivity</kwd><kwd>gluten sensitivity</kwd><kwd>wheat</kwd><kwd>ATI</kwd><kwd>amylase trypsin inhibitor</kwd><kwd>FODMAP</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="sec1-nutrients-09-01215"><title><text><SENT sid="10" pm="."><plain>1. </plain></SENT>
<SENT sid="11" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="12" pm="."><plain>Functional gastrointestinal disorders (FGDs) are common, and irritable bowel syndrome (IBS) is one of the most typical forms, affecting 11% of the adult population in developed countries [1]. </plain></SENT>
<SENT sid="13" pm="."><plain>IBS patients typically report intolerance to wheat, milk, onion, garlic, apples, alcohol, coffee, chili, and beans [2]. </plain></SENT>
<SENT sid="14" pm="."><plain>Non-coeliac gluten sensitivity, also known as wheat sensitivity, has attracted attention, both in the popular media and scientific literature [3,4,5,6]. </plain></SENT>
<SENT sid="15" pm="."><plain>Gluten per se has been long postulated to cause symptoms in some IBS patients, although 86% of patients with subjective wheat tolerance do not seem to respond to gluten pills in masked conditions [7], thus leaving the role of gluten unclear. </plain></SENT>
</text></p><p><text><SENT sid="16" pm="."><plain>A randomised 7-day study concluded that gluten, in low or high doses, did not worsen symptoms of IBS when compared to a whey protein-based placebo in low-FODMAP diet conditions [8]. </plain></SENT>
<SENT sid="17" pm="."><plain>Indeed, it has been acknowledged that it is unlikely that gluten alone is responsible for all wheat-related symptoms [9]. </plain></SENT>
<SENT sid="18" pm="."><plain>FODMAPs (Fermentable, Oligo-, Di-, Mono-saccharides and Polyols), i.e., rapidly fermented unabsorbed short-chain carbohydrates in wheat, can cause symptoms in the presence of typical IBS-related features, such as impaired handling of intestinal gas, abnormalities in bowel motility and visceral sensitivity [9,10]. </plain></SENT>
<SENT sid="19" pm="."><plain>The rapid fermentation of FODMAPs is suggested as a mechanism that triggers IBS symptoms. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>Preliminary in vitro and animal studies have indicated that amylase-trypsin inhibitors (ATIs) and other non-gluten proteins have a pro-inflammatory effect on intestinal epithelial cells and thus are theoretically capable of triggering gastrointestinal symptoms in humans [11,12,13]. </plain></SENT>
<SENT sid="21" pm="."><plain>However, there have been no randomised trials investigating ATIs. </plain></SENT>
<SENT sid="22" pm="."><plain>In fact, there is an on-going debate as to whether it is wheat proteins (such as ATIs and gluten) or FODMAPs that are the true triggers of wheat-related symptoms in FGD, or if their combination through a possible synergic effect is required for symptom aggravation. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>One method of decreasing the amount of FODMAPs and possibly the bioactivity of ATIs in bread (and thus theoretically improving its tolerability), is the utilization of prolonged fermentation processes in breadmaking. </plain></SENT>
<SENT sid="24" pm="."><plain>Sourdough fermentation activates some proteolytic and fructosidase enzymes in dough, and can thus decrease the amount of proteins and fructans in the end products [14,15,16,17]. </plain></SENT>
<SENT sid="25" pm="."><plain>The FODMAP content of sourdough bread can be reduced by up to 90% by utilizing a specific sourdough system, as demonstrated in our previous study [16]. </plain></SENT>
<SENT sid="26" pm="."><plain>Taken together, sourdough baking could theoretically result in wheat products with improved gastrointestinal tolerability. </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>Recent studies of subjective wheat sensitivity and IBS have suggested that gluten-free and low-FODMAP diets both reduce markers of low-grade inflammation [18,19]. </plain></SENT>
<SENT sid="28" pm="."><plain>Furthermore, one clinical study showed that kamut wheat, which is an ancient variant of modern wheat, has the potential to reduce inflammatory parameters in blood, as well as other symptoms, when compared to modern wheat [20]. </plain></SENT>
<SENT sid="29" pm="."><plain>Kamut wheat is lower in ATIs and FODMAPs than modern wheat [13,16]. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>The present study aimed to evaluate whether a sourdough wheat bread could reduce the symptoms of subjective wheat sensitivity and low-grade inflammation in IBS patients when compared to regular toast bread, baked with added gluten, larger amounts of baker’s yeast, and baking additives. </plain></SENT>
<SENT sid="31" pm="."><plain>Therefore, these effects were compared in a randomised, double-blinded, parallel group study, while patients were adhering to an otherwise gluten-free diet. </plain></SENT>
<SENT sid="32" pm="."><plain>We also aimed to specify the ATI and FODMAP content of the two breads. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec2-nutrients-09-01215"><title><text><SENT sid="33" pm="."><plain>2. </plain></SENT>
<SENT sid="34" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="sec2dot1-nutrients-09-01215"><title><text><SENT sid="35" pm="."><plain>2.1. </plain></SENT>
<SENT sid="36" pm="."><plain>Subjects and Study Design </plain></SENT>
</text></title><p><text><SENT sid="37" pm="."><plain>A total of 26 patients with IBS were recruited via the internet and from individuals attending a private hospital clinic (Aava Medical Centre, Helsinki, Finland). </plain></SENT>
<SENT sid="38" pm="."><plain>The eligibility inclusion criteria were as follows: (1) subjects aged 18–65 years; (2) presence of IBS, as defined by the Rome III criteria; and (3) subjective intolerance to wheat. </plain></SENT>
</text></p><p><text><SENT sid="39" pm="."><plain>The diagnosis of subjective wheat intolerance was based on the answer “yes” to the written screening question “I often experience different symptoms when I eat foodstuffs containing wheat and these symptoms are unpleasant”. </plain></SENT>
<SENT sid="40" pm="."><plain>Intolerance was confirmed by the study dietician during a telephone interview. </plain></SENT>
<SENT sid="41" pm="."><plain>The headline of the recruitment advertisement was also presented as the question: “Do you experience symptoms if you eat wheat?” We did not perform any blinded exposure tests for wheat, or any biochemical tests, as these do not exist for the diagnosis of wheat intolerance. </plain></SENT>
<SENT sid="42" pm="."><plain>The exclusion criteria included the presence of an organic gastrointestinal (GI) disease (such as inflammatory bowel disease or celiac disease), major abdominal surgery, any malignancy, pregnancy or breastfeeding, or use of medication potentially influencing gastrointestinal function. </plain></SENT>
</text></p><p><text><SENT sid="43" pm="."><plain>Study candidates were pre-screened by a study dietician. </plain></SENT>
<SENT sid="44" pm="."><plain>Those subjects meeting the preliminary inclusion criteria were subsequently referred to a screening consultation to a gastroenterologist, who then assessed their final eligibility for participating in the trial. </plain></SENT>
<SENT sid="45" pm="."><plain>Blood count, sedimentation rate, transglutaminase antibodies for celiac disease, and thyroid function tests were performed during the physician’s screening visit, if these tests had not already been performed within the past 12 months. </plain></SENT>
<SENT sid="46" pm="."><plain>Laboratory tests were conducted to ensure that the patients were eligible to participate in this trial; for example, all participants with elevated anti-tissue transglutaminase immunoglobulin A (IgA) antibodies were excluded. </plain></SENT>
<SENT sid="47" pm="."><plain>Patients were provided with obligatory written informed consent forms, which they all signed. </plain></SENT>
</text></p><p><text><SENT sid="48" pm="."><plain>The study protocol was approved by the ethics committee of the Hospital District of Helsinki and Uusimaa. </plain></SENT>
<SENT sid="49" pm="."><plain>The trial was registered at the United States (US) National Institutes of Health (ClinicalTrials.gov) with the trial number, NCT02572908. </plain></SENT>
</text></p><p><text><SENT sid="50" pm="."><plain>This study was a randomised, double blinded, parallel-group study with a 1-week run-in period, followed by a 1-week treatment period, in which the patients received either the sourdough wheat bread or yeast-fermented wheat bread. </plain></SENT>
<SENT sid="51" pm="."><plain>Subjects were advised to adhere to a gluten-free diet during the 2-week study duration, the details of which were described to participants by the study dietician. </plain></SENT>
<SENT sid="52" pm="."><plain>A gluten-free diet was recommended, in order to eliminate any potential confounding, attributable to other gluten-containing grains. </plain></SENT>
<SENT sid="53" pm="."><plain>The participants were asked to keep 3-day food records during the run-in and treatment period. </plain></SENT>
<SENT sid="54" pm="."><plain>Randomisation was performed in blocks of four, with a non-concealed allocation. </plain></SENT>
<SENT sid="55" pm="."><plain>Our statistician generated the computer-assisted randomisation list. </plain></SENT>
<SENT sid="56" pm="."><plain>The randomisation was blinded for both the participants and the investigators. </plain></SENT>
</text></p></sec><sec id="sec2dot2-nutrients-09-01215"><title><text><SENT sid="57" pm="."><plain>2.2. </plain></SENT>
<SENT sid="58" pm="."><plain>Study Breads </plain></SENT>
</text></title><p><text><SENT sid="59" pm="."><plain>The breads were manufactured by Fazer Bakeries (Vantaa, Finland). </plain></SENT>
<SENT sid="60" pm="."><plain>Both test breads were made using the same baker’s wheat flour (Fazer Mills, Lahti, Finland). </plain></SENT>
<SENT sid="61" pm="."><plain>The yeast-fermented bread was prepared in an industrial scale bakery, using a straight-dough bread making process that lasted approximately 2 h (including dough mixing, dough rest, moulding, proofing, and oven baking). </plain></SENT>
<SENT sid="62" pm="."><plain>The recipe of yeast-fermented bread contained added wheat gluten (2% of flour weight), bread improvers (such as emulsifiers), and sorbic acid (E200) as a preservative. </plain></SENT>
<SENT sid="63" pm="."><plain>The sourdough bread was produced in pilot scale, using a dough mixer and moulded by hand. </plain></SENT>
<SENT sid="64" pm="."><plain>The sourdough bread used wheat sourdough in the recipe with a long bulk fermentation stage. </plain></SENT>
<SENT sid="65" pm="."><plain>Overall, the dough stage took more than 12 h. </plain></SENT>
<SENT sid="66" pm="."><plain>No improvers or any added gluten or preservatives were used in the sourdough bread recipe. </plain></SENT>
</text></p><p><text><SENT sid="67" pm="."><plain>The breads were packaged in white plastic pouches so that participants could not compare the appearance of the study breads (Supplementary Materials Figure S1). </plain></SENT>
<SENT sid="68" pm="."><plain>The nutrient composition was analysed by Eurofins Scientific Finland (Food &amp; Agro, Raisio, Finland). </plain></SENT>
<SENT sid="69" pm="."><plain>The dietary fibre content of the breads was determined by using the American Association of Analytical Chemists (AOAC) 2011.25 method [21], a procedure that can discriminate between soluble and insoluble as well as between low and high molecular weight dietary fibres. </plain></SENT>
<SENT sid="70" pm="."><plain>Resistant starch was identified using the AOAC 2002.02 method [22]. </plain></SENT>
<SENT sid="71" pm="."><plain>The fructan content was measured by using the AOAC 999.03 method [23] (Megazyme assay kit K-FRUC, Megazyme International Ireland Ltd., Bray, Ireland). </plain></SENT>
<SENT sid="72" pm="."><plain>The nutritional composition of the study breads is presented in Table 1. </plain></SENT>
<SENT sid="73" pm="."><plain>The fructan content of sourdough bread represented more than a quarter (26%) of the fructan content of yeast-fermented bread, whereas the protein content was almost the same (94%) as in yeast-fermented wheat bread. </plain></SENT>
</text></p><p><text><SENT sid="74" pm="."><plain>Patients were advised to consume 150 g (six slices) of the study breads every day. </plain></SENT>
<SENT sid="75" pm="."><plain>Adherence to bread consumption was evaluated by patient entries into a tick-box diary for the treatment period and also by food records. </plain></SENT>
</text></p></sec><sec id="sec2dot3-nutrients-09-01215"><title><text><SENT sid="76" pm="."><plain>2.3. </plain></SENT>
<SENT sid="77" pm="."><plain>Determination of Monomeric, Dimeric and Tetrameric ATIs </plain></SENT>
</text></title><p><text><SENT sid="78" pm="."><plain>Sourdough bread and yeast-fermented bread were cut into small pieces, excluding the crusts. </plain></SENT>
<SENT sid="79" pm="."><plain>Albumins were extracted from 1 g of bread and flour samples, using a 20 mL buffer, containing 10 mM Tris-HCl and 0.1 M ethylenediaminetetraacetic acid (EDTA), with pH 7.5 at 4 °C for 1 h, with gentle shaking. </plain></SENT>
<SENT sid="80" pm="."><plain>Following centrifugation at 10,000× g at 4 °C, the supernatant was collected and precipitated with 50% ammonium sulphate at room temperature. </plain></SENT>
<SENT sid="81" pm="."><plain>The precipitates were dissolved in the same buffer and its protein concentration was determined by a detergent compatible (DC) protein assay Kit (5000111, Bio-Rad Laboratories Inc., Hercules, CA, USA) with a bovine serum albumin standard. </plain></SENT>
<SENT sid="82" pm="."><plain>The protein concentration of albumins from sourdough bread, yeast-fermented bread, and flour were adjusted to the same level. </plain></SENT>
<SENT sid="83" pm="."><plain>The albumin composition was analysed by SDS-PAGE with 12% Bis-Tris protein gel (NP0341BOX, ThermoFisher Scientific, Waltham, MA, USA). </plain></SENT>
<SENT sid="84" pm="."><plain>The albumin solutions were mixed with a lithium dodecyl sulfate (LDS) sample buffer (NP0008, ThermoFisher Scientific, Waltham, MA, USA), and with or without sample-reducing agent (NP0009, ThermoFisher Scientific, Waltham, MA, USA), and then boiled for 3 min. </plain></SENT>
<SENT sid="85" pm="."><plain>The running buffer was 3-Morpholinopropane-1-sulfonic acid (MOPS, NP0001), and the protein standard was SeeBlue Plus2 (LC5925, ThermoFisher Scientific, Waltham, MA, USA). </plain></SENT>
<SENT sid="86" pm="."><plain>The applied voltage was 200 V, and the run time was 50 min. </plain></SENT>
<SENT sid="87" pm="."><plain>The gel was stained with Coomassie R-250 brilliant blue. </plain></SENT>
<SENT sid="88" pm="."><plain>The monomer, dimer, and tetramer forms of ATI were recognised according to their molecular weights [24]. </plain></SENT>
</text></p></sec><sec id="sec2dot4-nutrients-09-01215"><title><text><SENT sid="89" pm="."><plain>2.4. </plain></SENT>
<SENT sid="90" pm="."><plain>Inflammatory Markers </plain></SENT>
</text></title><p><text><SENT sid="91" pm="."><plain>Inflammatory biomarkers, interleukin 8 (IL-8), interleukin 6 (IL-6) and lipopolysaccharide binding protein (LBP), were measured at baseline and after the treatment period with study breads. </plain></SENT>
<SENT sid="92" pm="."><plain>Serum IL-6 (BMS213HS, ThermoFisher Scientific, Waltham, MA USA), IL-8 (HS800, R&amp;D Systems, Abingdon, UK) and LBP (HK315-01, LBP; Hycult Biotech, Uden, The Netherlands) levels were quantified using sensitive enzyme-linked immunosorbent assays (ELISA). </plain></SENT>
</text></p></sec><sec id="sec2dot5-nutrients-09-01215"><title><text><SENT sid="93" pm="."><plain>2.5. </plain></SENT>
<SENT sid="94" pm="."><plain>Symptoms </plain></SENT>
</text></title><p><text><SENT sid="95" pm="."><plain>We constructed a questionnaire based on visual analogue scales (VAS 0–100 mm) to assess the severity of gastrointestinal symptoms and the other symptoms which could be related to IBS. </plain></SENT>
<SENT sid="96" pm="."><plain>Gastrointestinal symptoms were flatulence, bloating, diarrhoea, constipation, abdominal pain and cramps, borgorygmia, heartburn, nausea, dyspepsia, feeling of incomplete defecation, and urgency in defecation. </plain></SENT>
<SENT sid="97" pm="."><plain>Other symptoms were tiredness, joint symptoms, skin rash, decreased alertness, and loss of appetite. </plain></SENT>
<SENT sid="98" pm="."><plain>We did not formally validate the questionnaire with respect to the 17 different symptoms but it follows the practice and concept described by Francis et al. [25] and has been used previously [7,8,17]. </plain></SENT>
</text></p></sec><sec id="sec2dot6-nutrients-09-01215"><title><text><SENT sid="99" pm="."><plain>2.6. </plain></SENT>
<SENT sid="100" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="101" pm="."><plain>No sample size calculations were performed because of the pilot nature of the study and because no benchmark studies existed at the time of the initiation of the study. </plain></SENT>
<SENT sid="102" pm="."><plain>The patient characteristics are expressed as medians (range) for continuous variables and as number of patients (%) for categorical variables. </plain></SENT>
</text></p><p><text><SENT sid="103" pm="."><plain>Dietary intakes were measured during the run-in period and during the study breads. </plain></SENT>
<SENT sid="104" pm="."><plain>The Mann–Whitney U test was used to compare the study groups with respect to dietary intakes. </plain></SENT>
<SENT sid="105" pm="."><plain>The number of consumed slices of study breads was assessed every day during the treatment period. </plain></SENT>
<SENT sid="106" pm="."><plain>The Mann–Whitney U test was used to compare the average number of consumed slices of study breads. </plain></SENT>
<SENT sid="107" pm="."><plain>Dietary intakes are expressed as medians (inter-quartile range), due to skewed distributions. </plain></SENT>
</text></p><p><text><SENT sid="108" pm="."><plain>In regard to inflammatory markers, the study breads were compared using an analysis of covariance (ANCOVA), where the baseline was included as a covariate. </plain></SENT>
<SENT sid="109" pm="."><plain>The distributions of IL-8 and IL-6 were skewed to the right and were logarithmically (ln) transformed before analysis. </plain></SENT>
<SENT sid="110" pm="."><plain>Due to logarithmic transformation, the comparisons are given as ratios of sourdough bread/yeast-fermented bread. </plain></SENT>
</text></p><p><text><SENT sid="111" pm="."><plain>Gastrointestinal symptoms and the other symptoms were measured daily using VAS (0–100 mm) during the 7-day run-in period and during the 7-day treatment period with study breads. </plain></SENT>
<SENT sid="112" pm="."><plain>The run-in period was considered the baseline. </plain></SENT>
<SENT sid="113" pm="."><plain>The symptom scores (mean of weekly measurements) for all symptoms were calculated for baseline and for the treatment period. </plain></SENT>
<SENT sid="114" pm="."><plain>The total symptom scores were calculated for gastrointestinal symptoms (mean of 12 symptoms) and for other symptoms (mean of five symptoms). </plain></SENT>
<SENT sid="115" pm="."><plain>Analysis of covariance (ANCOVA) was used when the symptom scores were compared between the study breads and the symptom score during the baseline was included as a continuous covariate. </plain></SENT>
<SENT sid="116" pm="."><plain>The differences between study breads (sourdough bread vs. yeast-fermented bread) are given as baseline-adjusted means with 95% confidence intervals. </plain></SENT>
<SENT sid="117" pm="."><plain>The total score for the 12 gastrointestinal symptoms (gastrointestinal total score in Table 5) was the primary outcome variable and the total score for the five other symptoms (other symptoms total score in Table 6) was the key secondary variable. </plain></SENT>
<SENT sid="118" pm="."><plain>Other secondary outcome variables included the 12 gastrointestinal symptoms and 5 other symptoms, each individually, and the three inflammatory markers. </plain></SENT>
<SENT sid="119" pm="."><plain>No adjustment of p-values for multiple testing was performed for the secondary outcome variables. </plain></SENT>
<SENT sid="120" pm="."><plain>This is an unpowered exploratory pilot study and p-values should not be over-interpreted. </plain></SENT>
<SENT sid="121" pm="."><plain>Therefore, adjustment of p-values was not appropriate. </plain></SENT>
</text></p><p><text><SENT sid="122" pm="."><plain>The statistical analysis was performed using IBM SPSS Statistics for Windows (versions 22.0 and 23.0, IBM Corp, Armonk, NY, USA). </plain></SENT>
<SENT sid="123" pm="."><plain>A p-value &lt; 0.05 was considered statistically significant. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="sec3-nutrients-09-01215"><title><text><SENT sid="124" pm="."><plain>3. </plain></SENT>
<SENT sid="125" pm="."><plain>Results </plain></SENT>
</text></title><sec id="sec3dot1-nutrients-09-01215"><title><text><SENT sid="126" pm="."><plain>3.1. </plain></SENT>
<SENT sid="127" pm="."><plain>Baseline Characteristics </plain></SENT>
</text></title><p><text><SENT sid="128" pm="."><plain>In total, 26 subjects with IBS were recruited into the study and none withdrew during its duration. Table 2 depicts the characteristics of the subjects and Supplementary Materials Figure S2, the flow chart. </plain></SENT>
<SENT sid="129" pm="."><plain>All subjects, except one, were female (96%). </plain></SENT>
<SENT sid="130" pm="."><plain>Their median age was 43 (range 21–64) years and median body mass index was 25.0 (range 19.6–37.7) kg/m2. </plain></SENT>
<SENT sid="131" pm="."><plain>Four subjects (15%) reported minor use of wheat bread even though it evoked some subjective symptoms, and all of them were randomly assigned into the yeast-fermented bread group. </plain></SENT>
<SENT sid="132" pm="."><plain>More than half of the subjects (58%) reported following a gluten-free diet before study entry: 6/13 subjects in the sourdough and 9/13 in the yeast-fermented group. </plain></SENT>
<SENT sid="133" pm="."><plain>The rest reported tolerating wheat in minimal amounts occasionally. </plain></SENT>
</text></p></sec><sec id="sec3dot2-nutrients-09-01215"><title><text><SENT sid="134" pm="."><plain>3.2. </plain></SENT>
<SENT sid="135" pm="."><plain>Dietary Intakes </plain></SENT>
</text></title><p><text><SENT sid="136" pm="."><plain>Dietary intakes are reported in Table 3. </plain></SENT>
<SENT sid="137" pm="."><plain>Consumption of the study breads did not cause any statistically significant differences in the subjects’ energy intakes. </plain></SENT>
<SENT sid="138" pm="."><plain>Furthermore, there were no statistically significant differences in the intakes of fibre, carbohydrates, fat, or protein between the breads, even although the median fat intake between sourdough bread vs. yeast-fermented bread appeared to differ (79 g vs. 70 grams; p = 0.34). </plain></SENT>
<SENT sid="139" pm="."><plain>The changes in dietary intakes from baseline were also non-significant between study breads (data not shown). </plain></SENT>
</text></p><p><text><SENT sid="140" pm="."><plain>The median (IQR) intake of fructans from the breads was 0.08 (0.07–0.09) g/day with the sourdough wheat bread. </plain></SENT>
<SENT sid="141" pm="."><plain>This was significantly less than for the yeast-fermented bread, which yielded a value of 0.31 (0.24–0.3) g/day (p &lt; 0.001). </plain></SENT>
<SENT sid="142" pm="."><plain>There was no significant difference in the median number of bread slices consumed per day, i.e., 5.6 (139 g) for the sourdough bread and 5.4 (136 g) for its yeast-fermented counterpart (p = 0.92). </plain></SENT>
</text></p></sec><sec id="sec3dot3-nutrients-09-01215"><title><text><SENT sid="143" pm="."><plain>3.3. </plain></SENT>
<SENT sid="144" pm="."><plain>ATIs in the Supplied Breads </plain></SENT>
</text></title><p><text><SENT sid="145" pm="."><plain>Both bread samples showed fewer albumin bands than the flour sample, although the protein concentration was the same (Figure 1). </plain></SENT>
<SENT sid="146" pm="."><plain>The forms of ATI were identified on the basis of their molecular weight [24]. </plain></SENT>
<SENT sid="147" pm="."><plain>The band intensity of the tetrameric ATIs decreased in the order: flour &gt; yeast-fermented bread &gt; sourdough bread (Figure 1). </plain></SENT>
<SENT sid="148" pm="."><plain>The dimeric ATI bands in the flour sample were not the same as in the bread samples, and the intensity of these bands in the yeast-fermented bread was higher than in the sourdough bread (Figure 1). </plain></SENT>
<SENT sid="149" pm="."><plain>The intensity of the monomeric ATI bands decreased in the order: flour &gt; sourdough bread &gt; yeast-fermented bread (Figure 1). </plain></SENT>
<SENT sid="150" pm="."><plain>These results indicate that compared with the yeast-fermented bread, in the sourdough-fermented bread, the ATIs possibly unravelled from a tetrameric and dimeric form to a monomeric form, more intensively. </plain></SENT>
</text></p></sec><sec id="sec3dot4-nutrients-09-01215"><title><text><SENT sid="151" pm="."><plain>3.4. </plain></SENT>
<SENT sid="152" pm="."><plain>Inflammatory Markers </plain></SENT>
</text></title><p><text><SENT sid="153" pm="."><plain>We did not find significant differences between the study breads in the inflammatory markers (Table 4). </plain></SENT>
<SENT sid="154" pm="."><plain>Furthermore, the changes in inflammatory markers from baseline to the end of treatment period were not significant. </plain></SENT>
</text></p></sec><sec id="sec3dot5-nutrients-09-01215"><title><text><SENT sid="155" pm="."><plain>3.5. </plain></SENT>
<SENT sid="156" pm="."><plain>Symptoms </plain></SENT>
</text></title><p><text><SENT sid="157" pm="."><plain>VAS measurements of gastrointestinal symptoms did not reveal any statistically significant differences between the breads, when the weekly means were analysed (Table 5). </plain></SENT>
<SENT sid="158" pm="."><plain>However, tiredness, joint symptoms, and decreased alertness were more intense when the subjects were eating the sourdough bread (Table 6, p-values: 0.01, 0.03 and 0.003, respectively). </plain></SENT>
<SENT sid="159" pm="."><plain>There was no significant difference between the breads in terms of the total gastrointestinal symptom score (i.e., the mean of 12 symptoms) which was 27 (Standard deviation, SD 12) mm for the sourdough bread vs. 23 (SD 11) mm for the yeast-fermented bread. </plain></SENT>
<SENT sid="160" pm="."><plain>The baseline-adjusted difference between breads was 4 (95% CI: −4 to 11) mm, p = 0.33. </plain></SENT>
<SENT sid="161" pm="."><plain>There was a significant difference between the breads for the total non-gastrointestinal score, i.e., in other symptoms, the mean of five symptoms was 26 (SD 18) mm for the sourdough bread vs. 11 (SD 10) mm for the yeast-fermented bread. </plain></SENT>
<SENT sid="162" pm="."><plain>The baseline-adjusted difference between breads was 8 (95% CI: 2 to 14) mm, p = 0.02. </plain></SENT>
<SENT sid="163" pm="."><plain>The development of the symptoms during both the run-in period (days 1–7) and the treatment period (days 8–14) is illustrated in Figure 2 and in Appendix A (Figure A1a,b and Figure A2). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="sec4-nutrients-09-01215"><title><text><SENT sid="164" pm="."><plain>4. </plain></SENT>
<SENT sid="165" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="166" pm="."><plain>Our study provides some novel findings. </plain></SENT>
<SENT sid="167" pm="."><plain>As far as we know, we have demonstrated for the first time that ATI profiles of sourdough and yeast-fermented bread may differ. </plain></SENT>
<SENT sid="168" pm="."><plain>The molecular weights of the ATIs in this study are in agreement with published values of 60 kDa for tetramers, 24 kDa for dimers, and 12 kDa for monomers [24]. </plain></SENT>
<SENT sid="169" pm="."><plain>The lower content of ATI polymers (molecular weight &gt;14 kDa) in the sourdough bread than in the yeast-fermented bread is likely attributable to the more intensive reduction during sourdough fermentation, as shown by the greater intensity of the monomeric ATI bands in the sourdough lanes. </plain></SENT>
<SENT sid="170" pm="."><plain>Reduced ATIs per se have been reported to have less stimulatory activity against toll-like-receptor 4 (TLR4), and thus cause less innate immune reactions, in vitro and in animals [11,13], but no clinical trials had been performed on ATIs prior to our study. </plain></SENT>
</text></p><p><text><SENT sid="171" pm="."><plain>As far as we know, this is the first study to show that sourdough baking apparently more extensively unravels the tetrameric and dimeric form of ATIs when compared to yeast-fermented bread/wheat flour. </plain></SENT>
<SENT sid="172" pm="."><plain>This may be due to disulphide bond reduction, as sourdough redox conditions are known to be reductive [26]. </plain></SENT>
<SENT sid="173" pm="."><plain>The remaining ATIs in sourdough bread had weights of approximately 12 kDa, and thus were likely members of the ATI species, chloroform-methanolsoluble (CM) 0.28 [27]. </plain></SENT>
<SENT sid="174" pm="."><plain>ATIs of the CM 0.28 family do not have an especially pro-inflammatory effect in the gastrointestinal tract [11,13]. </plain></SENT>
<SENT sid="175" pm="."><plain>The sourdough bread was also absent of baking improvers (additives), when compared to yeast-fermented bread. </plain></SENT>
<SENT sid="176" pm="."><plain>Despite being lower in ATIs, fructans, and additives, the sourdough bread caused a rapid increase in many symptoms, and was not tolerated better than the yeast-fermented bread. </plain></SENT>
<SENT sid="177" pm="."><plain>This was in contrast to our hypothesis; the sourdough bread actually caused more non-gastrointestinal symptoms. </plain></SENT>
<SENT sid="178" pm="."><plain>We believe that the observed difference in non-gastrointestinal symptoms between the groups is likely to be due to chance, or due to a slight difference between the study groups at baseline (see discussion below). </plain></SENT>
<SENT sid="179" pm="."><plain>Theoretically, it is possible, albeit unlikely, that some unrecognized factor, such as metabolites in sourdough bread, might have caused the observed difference. </plain></SENT>
<SENT sid="180" pm="."><plain>The small sample size is a limitation of our study, and needs to be considered in this context. </plain></SENT>
<SENT sid="181" pm="."><plain>Our symptom evaluation was based on VAS measurements, which are not validated by dietary IBS studies, even if they are widely used. </plain></SENT>
<SENT sid="182" pm="."><plain>Clearly, further research is warranted to confirm the pilot results reported herein. </plain></SENT>
</text></p><p><text><SENT sid="183" pm="."><plain>Secondly, we demonstrated that the consumption of 5.4–5.6 slices of the wheat breads daily, as a sole source of wheat, did not increase inflammatory markers of innate immune activation, even though symptoms worsened rapidly. </plain></SENT>
<SENT sid="184" pm="."><plain>Therefore, the observed rapid worsening of symptoms, especially in sourdough bread, is unlikely to be caused by pro-inflammatory effects of wheat in the intestine. </plain></SENT>
<SENT sid="185" pm="."><plain>On the contrary, we argue that the major driver of the symptoms was the nocebo effect; participants may have expected adverse effects to any kind of wheat products, due to previous experiences and/or beliefs. </plain></SENT>
<SENT sid="186" pm="."><plain>Alternatively, both wheat breads per se might have caused gastrointestinal symptoms by forming a bolus in stomach, inhibiting gastric emptying, and reducing small bowel water, as a magnetic resonance imaging (MRI) study with whole wheat bread has suggested [28]. </plain></SENT>
</text></p><p><text><SENT sid="187" pm="."><plain>Seven days may be too short of a time period to detect changes in inflammatory markers, although previous experimental findings have suggested that pro-inflammatory reactions to wheat can be rapid [13,29]. </plain></SENT>
<SENT sid="188" pm="."><plain>Our first clinical results related to ATIs and markers of innate immunity urge the need for further studies, in order to clarify the effects of wheat products—such as bread and pasta—on innate immunity. </plain></SENT>
<SENT sid="189" pm="."><plain>It would be of interest to compare ATI profiles of sourdough wheat bread, wheat pasta and wheat flour. </plain></SENT>
<SENT sid="190" pm="."><plain>One would assume that pasta is higher in intact ATIs than sourdough bread, as it is not exposed to the fermentation process in food manufacturing. </plain></SENT>
<SENT sid="191" pm="."><plain>On the other hand, pasta is cooked in hot water and rinsed with water after cooking, which may remove a remarkable proportion of ATIs, as they are water-soluble albumin proteins. </plain></SENT>
</text></p><p><text><SENT sid="192" pm="."><plain>Finally, the FODMAP content of our sourdough wheat bread was reduced by 74%, as compared to yeast-fermented bread (fructans 0.23 g/100 g), making our sourdough wheat bread clearly lower in fructans (0.06 g/100 g) than rice cakes or rice bubbles [30]. </plain></SENT>
<SENT sid="193" pm="."><plain>Rice is known to be very low in fructans and well tolerated. </plain></SENT>
<SENT sid="194" pm="."><plain>Consequently, the remaining FODMAPs in sourdough wheat bread are unlikely triggers of symptoms unless bread is eaten in extreme portions per sitting. </plain></SENT>
<SENT sid="195" pm="."><plain>We also hasten to add that our results should not be interpreted as a critique against holistic low-FODMAP diets in the treatment of IBS, simply because the achieved daily reduction of intake of fructans was likely too small in total. </plain></SENT>
<SENT sid="196" pm="."><plain>The achieved difference in the FODMAP intake due to the breads was approximately 0.3 g/day, and such a difference represents just 20% of what has been shown to be a minimal meaningful difference, i.e., 1.5 g/day [17]. </plain></SENT>
<SENT sid="197" pm="."><plain>Even if we did not expect the difference in FODMAPs in the breads to play a major role, we hypothesized that the synergic effect of several potentially beneficial changes might play a role; after all, sourdough bread was found to have a lower content of FODMAPs, ATIs, gluten, and additives. </plain></SENT>
<SENT sid="198" pm="."><plain>Furthermore, it also seems that the yeast-fermented bread we used in our study was lower in FODMAPs than those that are marketed elsewhere, i.e., 0.23 g/100 g in our study compared to 0.68 g/100 g in Biesiekierski’s Australian study [30]. </plain></SENT>
</text></p><p><text><SENT sid="199" pm="."><plain>Our study has some limitations. </plain></SENT>
<SENT sid="200" pm="."><plain>As no clinical ATI studies were available at the time of the initiation of the study, we did not perform power calculations. </plain></SENT>
<SENT sid="201" pm="."><plain>A slight difference between the groups in the tolerance of wheat at baseline (Table 2) might have caused some bias into symptoms, favouring yeast-fermented bread; nevertheless, no differences were seen in the inflammatory markers at baseline, nor after the treatments, suggesting that any potentially existing bias was marginal. </plain></SENT>
<SENT sid="202" pm="."><plain>Finally, we did not compare in vitro inflammatory responses to ATIs of our study products and therefore were unable to quantify the theoretic inflammatory potential of the wheat products used—we are considering this in the future, in order to confirm our novel findings. </plain></SENT>
<SENT sid="203" pm="."><plain>Moreover, ATIs observed in this study were not identified by sequencing or immunological methods and must thus be considered likely ATIs. </plain></SENT>
</text></p><p><text><SENT sid="204" pm="."><plain>A crossover design might have been a more appropriate choice for the purpose of this study, rather than the parallel group design. </plain></SENT>
<SENT sid="205" pm="."><plain>However, there were two reasons we did not want to run a crossover study. </plain></SENT>
<SENT sid="206" pm="."><plain>Firstly, we considered that many patients might drop out from the study if they had to expose to themselves to a substantial amount gluten/wheat breads (approximately 150 g/day) during the separate periods, as they would have in a crossover design. </plain></SENT>
<SENT sid="207" pm="."><plain>Furthermore, the sourdough wheat bread and yeast-fermented wheat bread had different physical appearances (supplemental image). </plain></SENT>
<SENT sid="208" pm="."><plain>If all participants had been exposed to both breads, the key strength of our study—blinding—might have been lost. </plain></SENT>
<SENT sid="209" pm="."><plain>Participants might have guessed by appearance, which bread was sourdough, and which one was yeast-fermented. </plain></SENT>
<SENT sid="210" pm="."><plain>For these reasons we chose a parallel design. </plain></SENT>
<SENT sid="211" pm="."><plain>We emphasise that our pilot results must be considered a preliminary effort, paving the way for larger studies, and we recognise that the number of participants in our study was low for a parallel group design. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec id="sec5-nutrients-09-01215"><title><text><SENT sid="212" pm="."><plain>5. </plain></SENT>
<SENT sid="213" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="214" pm="."><plain>In conclusion, our pilot study did not reveal any significant differences in gastrointestinal tolerability or in low-grade inflammation when comparing sourdough wheat bread and yeast-fermented wheat bread, in subjects with irritable bowel syndrome/poor tolerance to wheat. </plain></SENT>
<SENT sid="215" pm="."><plain>Our findings, together with those of recent clinical trials on wheat sensitivity [31], underline the need for larger-scale clinical studies. </plain></SENT>
<SENT sid="216" pm="."><plain>Data from in vitro and animal studies cannot be extrapolated into clinical care and as such randomised studies are needed to verify pre-clinical outcomes. </plain></SENT>
<SENT sid="217" pm="."><plain>Furthermore, our study also highlights the fact that ATI analyses of wheat flour or other unfermented wheat products, cannot be extrapolated to fermented wheat products, such as sourdough bread. </plain></SENT>
<SENT sid="218" pm="."><plain>More studies with longer treatment periods and larger sample sizes are required to further clarify the role of ATIs and grain products as such in functional gastrointestinal disorders. </plain></SENT>
<SENT sid="219" pm="."><plain>The nocebo response seems to play a major role in IBS and subjective wheat sensitivity, and might explain our findings regarding non-gastrointestinal symptoms. </plain></SENT>
<SENT sid="220" pm="."><plain>The nocebo effect should be carefully addressed when planning future studies. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="221" pm="."><plain>Fazer Bakeries funded the study, provided the breads, and covered the costs of open access publishing. </plain></SENT>
<SENT sid="222" pm="."><plain>Authors thank the staff at Aava Medical Centre, Fazer Group and Booston for their kind assistance during various stages of the study. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="APPENDIX"><app-group><app id="app1-nutrients-09-01215"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="www.mdpi.com/2072-6643/9/11/1215/s1">www.mdpi.com/2072-6643/9/11/1215/s1</uri>, Figure S1: Flow chart, Figure S2: Pouched study breads.</p><supplementary-material content-type="local-data" id="nutrients-09-01215-s001"><media xlink:href="nutrients-09-01215-s001.pdf"><caption><p><text><SENT sid="223" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></app></app-group></SecTag><notes><title>Author Contributions</title><p>R.L., R.K., S.-M.H., J.L. and J.K. designed the study. R.L. was the principal investigator of this research and drafted the manuscript. R.L. and T.P. conducted the data analyses. X.H. and T.S.-S. performed ATIs analyses. H.S. analysed the inflammation markers. All authors critically reviewed the manuscript. All authors approved the final version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>R.L. has written a Finnish book on irritable bowel syndrome and diet. He is also a founder and owner of Booston Oy Ltd. (Helsinki, Finland), which provides IBS-related dietetic services to IBS patients, health care professionals, and various organisations. S.-M.H. and J.L. are employees of the Fazer Group (Helsinki, Finland). T.P. has received consultation fees from Booston Ltd. The other authors have no personal interests to declare.</p></notes><app-group><app id="app2-nutrients-09-01215"><title>Appendix A</title><SecTag type="FIG"><fig id="nutrients-09-01215-f003" orientation="portrait" position="anchor"><label>Figure A1</label><caption><p><text><SENT sid="224" pm="."><plain>The development of gastrointestinal symptoms (VAS 0–100 mm) over the course of study. </plain></SENT>
<SENT sid="225" pm="."><plain>Days 1–7 (strict gluten free diet) are considered as the baseline and days 8–14 as the actual treatment period with study breads. </plain></SENT>
<SENT sid="226" pm="."><plain>Circles with error bars indicate means (SEM). </plain></SENT>
<SENT sid="227" pm="."><plain>The symptoms are (a) flatulence, bloating, diarrhea, constipation, abdominal pain and abdominal cramps, and (b) borgorygmia, heartburn, dyspepsia, feeling of incomplete defecation, urgent need for defecation and nausea. </plain></SENT>
</text></p></caption><graphic xlink:href="nutrients-09-01215-g003a"/><graphic xlink:href="nutrients-09-01215-g003b"/></fig></SecTag><SecTag type="FIG"><fig id="nutrients-09-01215-f004" orientation="portrait" position="anchor"><label>Figure A2</label><caption><p><text><SENT sid="228" pm="."><plain>The development of other symptoms (VAS 0–100 mm) over the course of the study. </plain></SENT>
<SENT sid="229" pm="."><plain>Days 1–7 (strict gluten free diet) are considered as the baseline and days 8–14 as actual treatment period with study breads. </plain></SENT>
<SENT sid="230" pm="."><plain>Circles with error bars indicate means (SEM). </plain></SENT>
</text></p></caption><graphic xlink:href="nutrients-09-01215-g004"/></fig></SecTag></app></app-group><SecTag type="REF"><ref-list><title>References</title><ref id="B1-nutrients-09-01215"><text><SENT sid="231" pm="."><plain>1.CanavanC.WestJ.CardT.The epidemiology of irritable bowel syndromeClin. </plain></SENT>
<SENT sid="232" pm="."><plain>Epidemiol.20146718010.2147/CLEP.S40245<?supplied-pmid 24523597?>24523597 </plain></SENT>
</text></ref><ref id="B2-nutrients-09-01215"><text><SENT sid="233" pm="."><plain>2.SimrénM.MånssonA.LangkildeA.M.SvedlundJ.AbrahamssonH.BengtssonU.BjörnssonE.S.Food-related gastrointestinal symptoms in the irritable bowel syndromeDigestion20016310811510.1159/000051878<?supplied-pmid 11244249?>11244249 </plain></SENT>
</text></ref><ref id="B3-nutrients-09-01215"><text><SENT sid="234" pm="."><plain>3.HadjivassiliouM.SandersD.S.GrünewaldR.A.WoodroofeN.BoscoloS.AeschlimannD.Gluten sensitivity: From gut to brainLancet Neurol.2010931833010.1016/S1474-4422(09)70290-X20170845 </plain></SENT>
</text></ref><ref id="B4-nutrients-09-01215"><text><SENT sid="235" pm="."><plain>4.FasanoA.SaponeA.ZevallosV.SchuppanD.Nonceliac gluten sensitivityGastroenterology20151481195120410.1053/j.gastro.2014.12.049<?supplied-pmid 25583468?>25583468 </plain></SENT>
</text></ref><ref id="B5-nutrients-09-01215"><text><SENT sid="236" pm="."><plain>5.MakhariaA.CatassiC.MakhariaG.K.The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical DilemmaNutrients20157104171042610.3390/nu7125541<?supplied-pmid 26690475?>26690475 </plain></SENT>
</text></ref><ref id="B6-nutrients-09-01215"><text><SENT sid="237" pm="."><plain>6.MarkhamH.You Asked: Do I Have a Gluten Allergy?Time Magazine2942015Available online: <ext-link ext-link-type="uri" xlink:href="http://time.com/3838662/food-allergy-gluten-sensitivity/">http://time.com/3838662/food-allergy-gluten-sensitivity/</ext-link>(accessed on 30 August 2017) </plain></SENT>
</text></ref><ref id="B7-nutrients-09-01215"><text><SENT sid="238" pm="."><plain>7.ElliL.TombaC.BranchiF.RoncoroniL.LombardoV.BardellaM.T.BuscariniE.Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challengeNutrients201688410.3390/nu8020084<?supplied-pmid 26867199?>26867199 </plain></SENT>
</text></ref><ref id="B8-nutrients-09-01215"><text><SENT sid="239" pm="."><plain>8.BiesiekierskiJ.R.PetersS.L.NewnhamE.D.RosellaO.MuirJ.G.GibsonP.R.Effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydratesGastroenterology201314532032810.1053/j.gastro.2013.04.051<?supplied-pmid 23648697?>23648697 </plain></SENT>
</text></ref><ref id="B9-nutrients-09-01215"><text><SENT sid="240" pm="."><plain>9.De GiorgioR.VoltaU.GibsonP.R.Sensitivity to wheat, gluten and FODMAPs in IBS: Facts or fiction?Gut20166516917810.1136/gutjnl-2015-309757<?supplied-pmid 26078292?>26078292 </plain></SENT>
</text></ref><ref id="B10-nutrients-09-01215"><text><SENT sid="241" pm="."><plain>10.GibsonP.R.ShepherdS.J.Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approachJ. </plain></SENT>
<SENT sid="242" pm="."><plain>Gastroenterol. </plain></SENT>
<SENT sid="243" pm="."><plain>Hepatol.20102525225810.1111/j.1440-1746.2009.06149.x<?supplied-pmid 20136989?>20136989 </plain></SENT>
</text></ref><ref id="B11-nutrients-09-01215"><text><SENT sid="244" pm="."><plain>11.JunkerY.ZeissigS.KimS.J.BarisaniD.WieserH.SchuppanD.Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4J. </plain></SENT>
<SENT sid="245" pm="."><plain>Exp. </plain></SENT>
<SENT sid="246" pm="."><plain>Med.20122092395240810.1084/jem.20102660<?supplied-pmid 23209313?>23209313 </plain></SENT>
</text></ref><ref id="B12-nutrients-09-01215"><text><SENT sid="247" pm="."><plain>12.ValeriiM.C.RicciC.SpisniE.Di SilverstroR.CavazzaE.DinelliG.Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sourcesFood Chem.201517616717410.1016/j.foodchem.2014.12.061<?supplied-pmid 25624220?>25624220 </plain></SENT>
</text></ref><ref id="B13-nutrients-09-01215"><text><SENT sid="248" pm="."><plain>13.ZevallosV.F.RakerV.TenzerS.Jimenez-CalventeC.SchuppanD.Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid CellsGastroenterology20171521100111310.1053/j.gastro.2016.12.006<?supplied-pmid 27993525?>27993525 </plain></SENT>
</text></ref><ref id="B14-nutrients-09-01215"><text><SENT sid="249" pm="."><plain>14.ChavanS.ChavanS.Sourdough technology—A traditional way for wholesome foods: A reviewCompr. </plain></SENT>
<SENT sid="250" pm="."><plain>Rev. </plain></SENT>
<SENT sid="251" pm="."><plain>Food Sci. </plain></SENT>
<SENT sid="252" pm="."><plain>Food Saf.20111016918210.1111/j.1541-4337.2011.00148.x </plain></SENT>
</text></ref><ref id="B15-nutrients-09-01215"><text><SENT sid="253" pm="."><plain>15.LoponenJ.Sontag-StrohmT.VenäläinenJ.SalovaaraH.Prolamin hydrolysis in wheat sourdoughs with differing proteolytic activitiesJ. </plain></SENT>
<SENT sid="254" pm="."><plain>Agric. </plain></SENT>
<SENT sid="255" pm="."><plain>Food Chem.20075597898410.1021/jf062755g<?supplied-pmid 17263502?>17263502 </plain></SENT>
</text></ref><ref id="B16-nutrients-09-01215"><text><SENT sid="256" pm="."><plain>16.ZieglerJ.SteinerD.LonginC.FriedrichH.WürschumT.SchweiggertR.CarleR.Wheat and the irritable bowel syndrome—FODMAP levels of modern and ancient species and their retention during bread makingJ. </plain></SENT>
<SENT sid="257" pm="."><plain>Funct. </plain></SENT>
<SENT sid="258" pm="."><plain>Foods20162525726610.1016/j.jff.2016.05.019 </plain></SENT>
</text></ref><ref id="B17-nutrients-09-01215"><text><SENT sid="259" pm="."><plain>17.LaatikainenR.KoskenpatoJ.HongistoS.M.LoponenJ.PoussaT.KorpelaR.Randomised clinical trial: Low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndromeAliment. </plain></SENT>
<SENT sid="260" pm="."><plain>Pharmacol. </plain></SENT>
<SENT sid="261" pm="."><plain>Ther.20164446047010.1111/apt.13726<?supplied-pmid 27417338?>27417338 </plain></SENT>
</text></ref><ref id="B18-nutrients-09-01215"><text><SENT sid="262" pm="."><plain>18.HustoftT.N.HauskenT.YstadS.O.ValeurJ.BrokstadtK.HattlebakJ.G.LiedG.A.Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndromeNeurogastroenterol. </plain></SENT>
<SENT sid="263" pm="."><plain>Motil.20172910.1111/nmo.12969<?supplied-pmid 27747984?>27747984 </plain></SENT>
</text></ref><ref id="B19-nutrients-09-01215"><text><SENT sid="264" pm="."><plain>19.UhdeM.AjamianM.CaioG.DiGiorgioR.IndartA.AlaediniA.Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac diseaseGut2016651930193710.1136/gutjnl-2016-311964<?supplied-pmid 27459152?>27459152 </plain></SENT>
</text></ref><ref id="B20-nutrients-09-01215"><text><SENT sid="265" pm="."><plain>20.SofiF.WhittakerA.GoriA.M.CesariF.SurrentiE.CasiniA.Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: A double-blinded randomised dietary intervention trialBr. </plain></SENT>
<SENT sid="266" pm="."><plain>J. </plain></SENT>
<SENT sid="267" pm="."><plain>Nutr.20141111992199910.1017/S000711451400018X<?supplied-pmid 24521561?>24521561 </plain></SENT>
</text></ref><ref id="B21-nutrients-09-01215"><text><SENT sid="268" pm="."><plain>21.McClearyB.V.DeVriesJ.W.RaderJ.I.CohenG.ProskyL.MugfordD.C.OkumaK.J.Determination of insoluble, soluble, and total dietary fiber (CODEX definition) by enzymatic-gravimetric method and liquid chromatography: Collaborative studyAOAC Int.20129582484410.5740/jaoacint.CS2011_25 </plain></SENT>
</text></ref><ref id="B22-nutrients-09-01215"><text><SENT sid="269" pm="."><plain>22.McClearyB.V.MonaghanD.A.Measurement of resistant starchJ. </plain></SENT>
<SENT sid="270" pm="."><plain>AOAC Int.20028566567510.1002/9781118528723.ch07<?supplied-pmid 12083259?>12083259 </plain></SENT>
</text></ref><ref id="B23-nutrients-09-01215"><text><SENT sid="271" pm="."><plain>23.McClearyB.V.MurphyA.MugfordD.C.Measurement of total fructan in foods by enzymatic/spectrophotometric method: Collaborative studyJ AOAC Int.200083356364<?supplied-pmid 10772173?>10772173 </plain></SENT>
</text></ref><ref id="B24-nutrients-09-01215"><text><SENT sid="272" pm="."><plain>24.GomezL.Sanchez-MongeR.Garcia-OlmedoF.SalcedoG.Wheat tetrameric inhibitors of insect α-amylases: Alloploid heterosis at the molecular levelProc. </plain></SENT>
<SENT sid="273" pm="."><plain>Natl. </plain></SENT>
<SENT sid="274" pm="."><plain>Acad. </plain></SENT>
<SENT sid="275" pm="."><plain>Sci. </plain></SENT>
<SENT sid="276" pm="."><plain>USA1989863242324610.1073/pnas.86.9.3242<?supplied-pmid 16594035?>16594035 </plain></SENT>
</text></ref><ref id="B25-nutrients-09-01215"><text><SENT sid="277" pm="."><plain>25.FrancisC.Y.MorrisJ.WhorwellP.J.The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progressAliment. </plain></SENT>
<SENT sid="278" pm="."><plain>Pharmacol. </plain></SENT>
<SENT sid="279" pm="."><plain>Ther.19971139540210.1046/j.1365-2036.1997.142318000.x<?supplied-pmid 9146781?>9146781 </plain></SENT>
</text></ref><ref id="B26-nutrients-09-01215"><text><SENT sid="280" pm="."><plain>26.LoponenJ.KönigK.WuJ.GänzleM.G.Influence of thiol metabolism of lactobacilli on egg white proteins in wheat sourdoughsJ. </plain></SENT>
<SENT sid="281" pm="."><plain>Agric. </plain></SENT>
<SENT sid="282" pm="."><plain>Food Chem.2008563357336210.1021/jf703600t<?supplied-pmid 18412365?>18412365 </plain></SENT>
</text></ref><ref id="B27-nutrients-09-01215"><text><SENT sid="283" pm="."><plain>27.ChoudhuryA.MaedaK.MurayamaR.DiMagnoE.P.Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormonesGastroenterology19961111313132010.1053/gast.1996.v111.pm8898646<?supplied-pmid 8898646?>8898646 </plain></SENT>
</text></ref><ref id="B28-nutrients-09-01215"><text><SENT sid="284" pm="."><plain>28.MarcianiL.PritchardS.E.Hellier-WoodsC.CostiganC.SpillerR.C.Delayed gastric emptying and reduced postprandial small bowel water content of equicaloric whole meal bread versus rice meals in healthy subjects: Novel MRI insightsEur. </plain></SENT>
<SENT sid="285" pm="."><plain>J. </plain></SENT>
<SENT sid="286" pm="."><plain>Clin. </plain></SENT>
<SENT sid="287" pm="."><plain>Nutr.20136775475810.1038/ejcn.2013.78<?supplied-pmid 23594839?>23594839 </plain></SENT>
</text></ref><ref id="B29-nutrients-09-01215"><text><SENT sid="288" pm="."><plain>29.Fritscher-RavensA.SchuppanD.EllrichmannM.SchochS.MillaP.J.Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndromeGastroenterology20141471012102010.1053/j.gastro.2014.07.046<?supplied-pmid 25083606?>25083606 </plain></SENT>
</text></ref><ref id="B30-nutrients-09-01215"><text><SENT sid="289" pm="."><plain>30.BiesiekierskiJ.R.RosellaO.RoseR.LielsK.BarrettJ.S.MuirJ.G.Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cerealsJ. </plain></SENT>
<SENT sid="290" pm="."><plain>Hum. </plain></SENT>
<SENT sid="291" pm="."><plain>Nutr. </plain></SENT>
<SENT sid="292" pm="."><plain>Diet.20112415417610.1111/j.1365-277X.2010.01139.x<?supplied-pmid 21332832?>21332832 </plain></SENT>
</text></ref><ref id="B31-nutrients-09-01215"><text><SENT sid="293" pm="."><plain>31.Molina-InfanteJ.CarroccioA.Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients after Gluten Challenge in Double-Blind, Placebo-Controlled TrialsClin. </plain></SENT>
<SENT sid="294" pm="."><plain>Gastroenterol. </plain></SENT>
<SENT sid="295" pm="."><plain>Hepatol.20171533934810.1016/j.cgh.2016.08.007<?supplied-pmid 27523634?>27523634 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="nutrients-09-01215-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="296" pm="."><plain>SDS-PAGE of albumins from bread and flour. </plain></SENT>
<SENT sid="297" pm="."><plain>Lanes 1 and 8: protein molecular weight standard; lanes 2 and 3: albumin extract from sourdough bread; lanes 4 and 5: albumin extract from yeast-fermented bread; lanes 6 and 7: albumin extract from wheat flour. </plain></SENT>
<SENT sid="298" pm="."><plain>For lanes 2, 4, and 6, marked ‘+’, samples were reduced with dithiothreitol, and those marked ‘−’ were without a reduction. </plain></SENT>
<SENT sid="299" pm="."><plain>Arrows indicate α-amylase/trypsin inhibitors (ATIs) in different forms, monomer in lane 2, dimer in lane 4 and tetramer in lane 6. </plain></SENT>
<SENT sid="300" pm="."><plain>kDa: kilodalton. </plain></SENT>
</text></p></caption><graphic xlink:href="nutrients-09-01215-g001"/></fig></SecTag><SecTag type="FIG"><fig id="nutrients-09-01215-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="301" pm="."><plain>The development of total scores for gastrointestinal symptoms (VAS 0–100 mm) over the course of the study. </plain></SENT>
<SENT sid="302" pm="."><plain>Days 1–7 (strict gluten free diet) are considered as baseline and days 8–14 as the actual treatment period with study breads. </plain></SENT>
<SENT sid="303" pm="."><plain>Circles with error bars indicate means (standard error of mean, SEM). </plain></SENT>
</text></p></caption><graphic xlink:href="nutrients-09-01215-g002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="304" pm="."><plain>Nutritional composition of the study breads. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>Sourdough Bread */100 g </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>Yeast-Fermented Bread */100 g </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>Energy, kJ (kcal) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>972 (229) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>1116 (264) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>Protein, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>9.3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>9.9 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Gluten, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>4.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>6.0 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>Fat, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>1.2 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>2.4 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>Carbohydrates, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>43.4 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>48.4 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>Dietary fibre, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>3.9 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>4.5 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>Salt, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>1.2 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>1.1 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Fructans, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>0.06 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>0.23 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>LMWDF, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>0.9 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>1.0 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>Insoluble HMWDF, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>1.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>Soluble HMWDF, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>1.2 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>1.4 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>Resistant starch, g </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>0.7 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>0.8 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>Dominant ATI form </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>Monomeric </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>Dimeric </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>Additives/Improvers </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>Not present </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>Present </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>LMWDF: Low molecular weight dietary fibre; HMWDF: High molecular weight dietary fibre; ATI: alpha-amylase/trypsin inhibitor. * Participants were supplied with and instructed to consume 150 grams of each bread/day.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="349" pm="."><plain>Baseline characteristics of the participants. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>Characteristics </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>Sourdough Bread (n = 13) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>Yeast-Fermented Bread (n = 13) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>Total (n = 26) </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>Females </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>12 (92) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>13 (100) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>25 (96) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>Age (years) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>39 (21–56) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>47 (24–64) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>43 (21–64) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>Body mass index, BMI (kg/m2) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>25.1 (20.2–37.7) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>24.9 (19.6–31.8) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>25.0 (19.6–37.7) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>Weight (kg) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>70 (59–109) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>65 (54–92) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>68 (54–109) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>Self-reported daily consumption of any bread (number of slices) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>3.0 (1–4) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>2.5 (1–7.5) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>3.0 (1–7.5) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>Occasional use of some wheat bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>0 (0) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>4 (31) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>4 (15) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Results are given as median (range) and as <italic>n</italic> (%) of subjects.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t003_Table 3</object-id><label>Table 3</label><caption><p><text><SENT sid="378" pm="."><plain>Dietary intake during the baseline and during consumption of the study breads. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>Sourdough Bread (n = 13) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>Yeast-Fermented Bread (n = 13) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>p-Value * </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="382" pm="."><plain>Energy, kJ/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>8422 (7521–9530) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>8177 (7062–8425) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="386" pm="."><plain>0.80 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>8214 (7826–8558) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>7609 (6498–9899) </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="390" pm="."><plain>Energy, kcal/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>2012 (1797–2276) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>1953 (1687–2012) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="394" pm="."><plain>0.84 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>1962 (1869–2044) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>1818 (1553–2365) </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="398" pm="."><plain>Carbohydrates, g/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>196 (147–236) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>182 (161–215) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="402" pm="."><plain>0.88 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>198 (169–221) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>181 (166–281) </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="406" pm="."><plain>Protein, g/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>88 (64–103) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>78 (64–102) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="410" pm="."><plain>0.36 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>89 (85–107) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>85 (64–107) </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="414" pm="."><plain>Fat, g/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>89 (66–103) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>73 (69–88) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="418" pm="."><plain>0.34 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>79 (78–86) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>70 (53–83) </plain></SENT>
</text></td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="422" pm="."><plain>Dietary fibre, g/day </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>Baseline </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>20 (15–22) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>16 (14–22) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="426" pm="."><plain>0.36 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>Study bread </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>20 (17–22) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>16 (15–24) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Results are given as median (inter-quartile range). * Dietary intakes during study breads and also the changes from baseline were compared between the study breads with the Mann–Whitney U test. <italic>p</italic>-values for changes from baseline varied between 0.13 and 0.96.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t004_Table 4</object-id><label>Table 4</label><caption><p><text><SENT sid="430" pm="."><plain>Interleukin-8 (IL-8; pg/mL), interleukin-6 (IL-6; pg/mL) and lipopolysaccharide binding protein (LBP; µg/mL) at baseline and after the treatment periods with study breads. </plain></SENT>
<SENT sid="431" pm="."><plain>Confidence intervals (CI) are in parentheses. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text></text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="432" pm="."><plain>Sourdough Bread (n = 12) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="433" pm="."><plain>Yeast-Fermented Bread (n = 12) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="434" pm="."><plain>Sourdough Bread vs. Yeast-Fermented Bread </plain></SENT>
</text></th></tr><tr><th rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="435" pm="."><plain>Baseline </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="436" pm="."><plain>Study Bread </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="437" pm="."><plain>Baseline </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="438" pm="."><plain>Study Bread </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="439" pm="."><plain>Baseline-Adjusted Difference </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>Ratio (95% CI) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>p-Value * </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>IL-8 (pg/mL) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>11.6 (9.8–13.8) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>11.2 (10.1–12.4) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>13.7 (11.0–17.0) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>13.3 (10.5–16.9) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>0.91 (0.73 to 1.14) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>0.38 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>IL-6 (pg/mL) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>0.67 (0.34–1.32) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>0.72 (0.42–1.21) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>1.22 (0.78–1.90) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>1.09 (0.73–1.64) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>1.01 (0.74 to 1.39) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>0.38 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>Mean (95% CI) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>p-Value </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>LBP (µg/mL) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>8.39 (5.16–11.62) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>8.48 (5.09–11.88) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>8.15 (6.45–9.85) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>9.42 (7.15–11.70) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>−1.19 (−2.55 to 0.17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>0.08 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Results are given as geometric means (95% CI) for IL-8 and IL-6 and as the arithmetic mean (95% CI) for LBP. * The study breads were compared using an analysis of covariance (ANCOVA), where baseline was included as a covariate. IL-8 and IL-6 were logarithmically (ln) transformed before the analysis.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t005_Table 5</object-id><label>Table 5</label><caption><p><text><SENT sid="465" pm="."><plain>Gastrointestinal symptoms (visual analogue scales, VAS 0–100 mm) and gastrointestinal total score during the baseline (mean of days 1–7) and during consumption of the study breads (mean of days 8–14). </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="466" pm="."><plain>Symptom </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="467" pm="."><plain>Sourdough Bread (n = 13) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="468" pm="."><plain>Yeast-Fermented Bread (n = 13) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="469" pm="."><plain>Sourdough Bread vs. Yeast-Fermented Bread </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>Baseline </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>Study Bread </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>Baseline </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>Study Bread </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>Baseline-Adjusted Difference </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>p-Value * </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>Flatulence </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>25 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>37 (20) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>22 (12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>32 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>3 (−11 to 17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>0.66 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>Bloating </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>23 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>38 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>23 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>38 (20) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>1 (−13 to 15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>0.93 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Diarrhoea </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>10 (8) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>13 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>12 (10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>13 (10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>1 (−9 to 10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>0.90 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>Constipation </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>16 (13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>22 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>14 (13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>24 (20) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>−4 (−16 to 8) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>0.54 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>Abdominal pain </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>16 (14) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>32 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>20 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>29 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>4 (−7 to 15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>0.44 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>Abdominal cramps </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>12 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>27 (19) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>10 (10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>16 (13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>10 (−1 to 21) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>0.06 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>Borgorygmia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>20 (20) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>34 (24) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>19 (12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>23 (13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>10 (−1 to 21) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>0.07 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>Heartburn </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>13 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>18 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>9 (7) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>12 (10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>3 (−5 to 12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>0.43 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>Dyspepsia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>14 (14) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>29 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>18 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>24 (23) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>8 (−6 to 22) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>0.25 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>Feeling of incomplete defecation </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>30 (25) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>37 (25) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>24 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>32 (24) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>−1 (−14 to 13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>0.93 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>Urgent need for defecation </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>18 (14) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>21 (19) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>20 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>21 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>1 (−10 to 12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>0.90 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>Nausea </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>12 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>21 (15) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>10 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>15 (16) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>5 (−4 to 13) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>0.29 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>Gastrointestinal total score </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>17 (12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>27 (12) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>17 (9) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>23 (11) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>4 (−4 to 11) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>0.33 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Results are given as mean (SD) and mean (95% CI). * The study breads were compared using the analysis of covariance (ANCOVA), where the symptom score during the baseline was included as a covariate.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="nutrients-09-01215-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-01215-t006_Table 6</object-id><label>Table 6</label><caption><p><text><SENT sid="567" pm="."><plain>Other symptoms (VAS 0–100 mm) and other symptoms total score during the baseline (mean of days 1–7) and during the consumption of the study breads (mean of days 8–14). </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="568" pm="."><plain>Symptom </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="569" pm="."><plain>Sourdough Bread (n = 13) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="570" pm="."><plain>Yeast-Fermented Bread (n = 13) </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="571" pm="."><plain>Sourdough Bread vs. Yeast-Fermented Bread </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>Baseline </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>Study Bread </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>Baseline </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>Study Bread </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>Baseline-Adjusted Difference </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>p-Value * </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>Tiredness </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>30 (24) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>40 (25) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>17 (15) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>14 (15) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>16 (4 to 27) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>0.01 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>Joint symptoms </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>17 (19) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>23 (21) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>9 (14) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>7 (13) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>7 (1 to 13) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>0.03 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>Skin rash </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>11 (18) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>14 (18) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>3.5 (3) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>5 (5) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>3 (−5 to 11) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>0.45 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>Decreased alertness </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>22 (25) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>35 (26) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>12 (15) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>13 (12) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>14 (5 to 22) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>0.003 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>Loss of appetite </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>12 (18) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>19 (15) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>9 (12) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>15 (15) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>2 (−6 to 9) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>0.62 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>Other symptoms total score </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>19 (17) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>26 (18) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>10 (11) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>11 (10) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>8 (2 to 14) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>0.02 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Results are given as mean (SD) and mean (95% CI). * The study breads were compared using the analysis of covariance (ANCOVA), where the symptom score during the baseline was included as a covariate.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
